ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Beijing Aosaikang Pharmaceutical Co., Ltd. clinical trials

Also known as ASK Pharm.

Part of Nanjing Aosaikang Investment Management Co., Ltd., which holds 34.20% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 19 studies whose lead sponsor is Beijing Aosaikang Pharmaceutical Co., Ltd. or one of 2 companies grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Beijing Aosaikang Pharmaceutical with AstraZeneca and Jiangsu HengRui Medicine →

Pipeline: 6 programs

Each counted once: 6 with a study Beijing Aosaikang Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Beijing Aosaikang Pharmaceutical Co., Ltd.’s own registered studies; Beijing Aosaikang Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Beijing Aosaikang Pharmaceutical Co., Ltd.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

5 of Beijing Aosaikang Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 3D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 2O
  13. N

Add all 5 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 19 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now737%Recruiting 4 · Not yet recruiting 3
  • Under way, not recruiting526%
  • Completed316%
  • Status unknown or other421%

Phase

  • Phase 112
  • Phase 26
  • Phase 35

Where

  • China17
  • Australia1
  • United States1

Over the years

  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 322
  7. 23
  8. 24
  9. 25
  10. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Beijing Aosaikang Pharmaceutical Co., Ltd.

  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • AskGene Pharma, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →

Studies

Recruiting first, then most recently updated. Showing 19 of 19.